Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USA.
Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USA.
复制标题
DOI：
10.1016/j.jve.2023.100315
复制
发表时间：
2023-03
影响因子：
5.5
通讯作者：
Stevenson, Mario
中科院分区：
文献类型：
--
作者：
Archin, N.;Bar, K. J.;Burdo, T.;Caskey, M.;Chahroudi, A.;Farzan, M.;Ho, Y. -C.;Jones, R. B.;Kearney, Mary;Kuritzkes, D.;Margolis, D.;Martinez-Picado, J.;Okoye, A.;Salgado, M.;Stevenson, Mario
The International Workshop on HIV Persistence during Therapy provides a forum in which HIV/AIDS researchers gather to share the latest research findings related to viral reservoirs and cure. The Tenth Workshop, which was attended by over 400 delegates, extended over 4 days and comprised eight sessions covering topics from the basic science of viral persistence to therapeutic approaches to HIV cure. Furthermore, satellite sessions on the first day of the Conference featuring cure research endeavours being pursued by the Bill and Melinda Gates Foundation as well as those being coordinated under the National Institutes of Health Martin Delaney Collaboratory program, provided important updates on research advances being made in these initiatives. As with previous conferences, the International Workshop on HIV Persistence during Therapy is primarily abstract-driven with only one invited talk for each of the sessions. This format, therefore, increases the number of presentations from early-stage investigators. Furthermore, presentations by Community representatives illustrated approaches to creating cure research literacy with effective messaging for the Community. The following article offers a synopsis of the meeting sessions. Due to space constraints, some presentations may have only been briefly discussed. Nevertheless, the Workshop abstracts can be found online (https://www/sciencedirect.com/journal/journal-of-virus-eradication/vol/8/suppl/S).
登录
查看更多内容
影响因子：
11.8
作者：
Caskey, Marina;Kuritzkes, Daniel R.
通讯作者：
Kuritzkes, Daniel R.
影响因子：
64.5
作者：
Einkauf KB;Osborn MR;Gao C;Sun W;Sun X;Lian X;Parsons EM;Gladkov GT;Seiger KW;Blackmer JE;Jiang C;Yukl SA;Rosenberg ES;Yu XG;Lichterfeld M
通讯作者：
Lichterfeld M
影响因子：
82.9
作者：
Bailon, Lucia;Llano, Anuska;Rivero, Angel
通讯作者：
Rivero, Angel
HIV-1患者的抗逆转录病毒治疗启动时，使用3bnc117和romidepsin的早期干预：1b/2a期随机试验。
影响因子：
82.9
作者：
Gunst, Jesper D.;Pahus, Marie H.;Rosas-Umbert, Miriam;Lu, I-Na;Benfield, Thomas;Nielsen, Henrik;Johansen, Isik S.;Mohey, Rajesh;Ostergaard, Lars;Klastrup, Vibeke;Khan, Maryam;Schleimann, Mariane H.;Olesen, Rikke;Stovring, Henrik;Denton, Paul W.;Kinloch, Natalie N.;Copertino, Dennis C.;Ward, Adam R.;Alberto, Winiffer D. Conce;Nielsen, Silke D.;Puertas, Maria C.;Ramos, Victor;Reeves, Jacqueline D.;Petropoulos, Christos J.;Martinez-Picado, Javier;Brumme, Zabrina L.;Jones, R. Brad;Fox, Julie;Tolstrup, Martin;Nussenzweig, Michel C.;Caskey, Marina;Fidler, Sarah;Sogaard, Ole S.
通讯作者：
Sogaard, Ole S.
DOI：
10.1172/jci154422
发表时间：
2022-04-01
期刊：
The Journal of clinical investigation
影响因子：
--
作者：
Duette G;Hiener B;Morgan H;Mazur FG;Mathivanan V;Horsburgh BA;Fisher K;Tong O;Lee E;Ahn H;Shaik A;Fromentin R;Hoh R;Bacchus-Souffan C;Nasr N;Cunningham AL;Hunt PW;Chomont N;Turville SG;Deeks SG;Kelleher AD;Schlub TE;Palmer S
通讯作者：
Palmer S